In 2017, Masahiko Watanabe's team found that the expression of KK-LC-1 in stage I gastric cancer was very high, suggesting that KK-LC-1 can be used as a potential marker for the early diagnosis and treatment of gastric cancer [49]. The gene discussed is CT83; the disease is gastric cancer.